Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

The effectiveness of the anti-CD11d treatment is reduced in rat models of spinal cord injury that produce significant levels of intraspinal hemorrhage.

Geremia NM, Hryciw T, Bao F, Streijger F, Okon E, Lee JHT, Weaver LC, Dekaban GA, Kwon BK, Brown A.

Exp Neurol. 2017 Sep;295:125-134. doi: 10.1016/j.expneurol.2017.06.002. Epub 2017 Jun 3.

2.

Importance of local values to successful conservation: response to Jacquet and Delon.

Naidoo R, Weaver LC, Diggle RW, Matongo G, Stuart-Hill G, Thouless C.

Conserv Biol. 2016 Aug;30(4):912-3. doi: 10.1111/cobi.12750. Epub 2016 May 27. No abstract available.

PMID:
27108480
3.

Complementary benefits of tourism and hunting to communal conservancies in Namibia.

Naidoo R, Weaver LC, Diggle RW, Matongo G, Stuart-Hill G, Thouless C.

Conserv Biol. 2016 Jun;30(3):628-38. doi: 10.1111/cobi.12643. Epub 2016 Jan 8.

PMID:
26537845
4.

CD11d integrin blockade reduces the systemic inflammatory response syndrome after traumatic brain injury in rats.

Weaver LC, Bao F, Dekaban GA, Hryciw T, Shultz SR, Cain DP, Brown A.

Exp Neurol. 2015 Sep;271:409-22. doi: 10.1016/j.expneurol.2015.07.003. Epub 2015 Jul 11.

5.

Cancer survivorship care: Implications for primary care advanced practice nurses.

Weaver LC, Jessup A, Mayer DK.

Nurse Pract. 2013 Nov 10;38(11):1-11. doi: 10.1097/01.NPR.0000435784.40143.62. Review.

PMID:
24141542
6.

Temporal changes in monocyte and macrophage subsets and microglial macrophages following spinal cord injury in the Lys-Egfp-ki mouse model.

Thawer SG, Mawhinney L, Chadwick K, de Chickera SN, Weaver LC, Brown A, Dekaban GA.

J Neuroimmunol. 2013 Aug 15;261(1-2):7-20. doi: 10.1016/j.jneuroim.2013.04.008. Epub 2013 May 24.

PMID:
23711349
7.

Treatment with an anti-CD11d integrin antibody reduces neuroinflammation and improves outcome in a rat model of repeated concussion.

Shultz SR, Bao F, Weaver LC, Cain DP, Brown A.

J Neuroinflammation. 2013 Feb 15;10:26. doi: 10.1186/1742-2094-10-26.

8.

Disordered cardiovascular control after spinal cord injury.

Weaver LC, Fleming JC, Mathias CJ, Krassioukov AV.

Handb Clin Neurol. 2012;109:213-33. doi: 10.1016/B978-0-444-52137-8.00013-9. Review.

PMID:
23098715
9.

A CD11d monoclonal antibody treatment reduces tissue injury and improves neurological outcome after fluid percussion brain injury in rats.

Bao F, Shultz SR, Hepburn JD, Omana V, Weaver LC, Cain DP, Brown A.

J Neurotrauma. 2012 Sep 20;29(14):2375-92. doi: 10.1089/neu.2012.2408. Epub 2012 Jul 12.

10.

Differential detection and distribution of microglial and hematogenous macrophage populations in the injured spinal cord of lys-EGFP-ki transgenic mice.

Mawhinney LA, Thawer SG, Lu WY, Rooijen Nv, Weaver LC, Brown A, Dekaban GA.

J Neuropathol Exp Neurol. 2012 Mar;71(3):180-97. doi: 10.1097/NEN.0b013e3182479b41.

PMID:
22318123
11.

The systemic inflammatory response after spinal cord injury in the rat is decreased by α4β1 integrin blockade.

Bao F, Omana V, Brown A, Weaver LC.

J Neurotrauma. 2012 May 20;29(8):1626-37. doi: 10.1089/neu.2011.2190. Epub 2012 Feb 29.

12.

The dark side of neuroplasticity.

Brown A, Weaver LC.

Exp Neurol. 2012 May;235(1):133-41. doi: 10.1016/j.expneurol.2011.11.004. Epub 2011 Nov 12. Review.

13.

Anti-CD11d monoclonal antibody treatment for rat spinal cord compression injury.

Weaver LC, Dekaban GA, Brown A.

Exp Neurol. 2012 Feb;233(2):612-4. doi: 10.1016/j.expneurol.2011.06.009. Epub 2011 Nov 10.

PMID:
22078757
14.

CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury.

Bao F, Brown A, Dekaban GA, Omana V, Weaver LC.

Exp Neurol. 2011 Oct;231(2):272-83. doi: 10.1016/j.expneurol.2011.07.001. Epub 2011 Jul 19.

15.

A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury.

Bao F, Fleming JC, Golshani R, Pearse DD, Kasabov L, Brown A, Weaver LC.

J Neurotrauma. 2011 Jun;28(6):1035-49. doi: 10.1089/neu.2010.1575. Epub 2011 May 5.

16.

Human spinal cord injury causes specific increases in surface expression of β integrins on leukocytes.

Bao F, Bailey CS, Gurr KR, Bailey SI, Rosas-Arellano MP, Brown A, Dekaban GA, Weaver LC.

J Neurotrauma. 2011 Feb;28(2):269-80. doi: 10.1089/neu.2010.1618.

17.

A grading system to evaluate objectively the strength of pre-clinical data of acute neuroprotective therapies for clinical translation in spinal cord injury.

Kwon BK, Okon EB, Tsai E, Beattie MS, Bresnahan JC, Magnuson DK, Reier PJ, McTigue DM, Popovich PG, Blight AR, Oudega M, Guest JD, Weaver LC, Fehlings MG, Tetzlaff W.

J Neurotrauma. 2011 Aug;28(8):1525-43. doi: 10.1089/neu.2010.1296. Epub 2010 Oct 18. Review.

18.

Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes.

Fleming JC, Bao F, Cepinskas G, Weaver LC.

Inflamm Res. 2010 Aug;59(8):647-57. doi: 10.1007/s00011-010-0177-5. Epub 2010 Mar 7.

PMID:
20213330
19.

A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury.

Kwon BK, Okon E, Hillyer J, Mann C, Baptiste D, Weaver LC, Fehlings MG, Tetzlaff W.

J Neurotrauma. 2011 Aug;28(8):1545-88. doi: 10.1089/neu.2009.1149. Epub 2010 Apr 14. Review.

20.

A systematic review of directly applied biologic therapies for acute spinal cord injury.

Kwon BK, Okon EB, Plunet W, Baptiste D, Fouad K, Hillyer J, Weaver LC, Fehlings MG, Tetzlaff W.

J Neurotrauma. 2011 Aug;28(8):1589-610. doi: 10.1089/neu.2009.1150. Epub 2010 Jun 16. Review.

21.

Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy.

Fleming JC, Bao F, Chen Y, Hamilton EF, Gonzalez-Lara LE, Foster PJ, Weaver LC.

J Neurosurg Spine. 2009 Nov;11(5):575-87. doi: 10.3171/2009.6.SPINE08915.

PMID:
19929361
22.

Increased oxidative activity in human blood neutrophils and monocytes after spinal cord injury.

Bao F, Bailey CS, Gurr KR, Bailey SI, Rosas-Arellano MP, Dekaban GA, Weaver LC.

Exp Neurol. 2009 Feb;215(2):308-16. doi: 10.1016/j.expneurol.2008.10.022. Epub 2008 Nov 13.

PMID:
19056384
23.

Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function.

Fleming JC, Bao F, Chen Y, Hamilton EF, Relton JK, Weaver LC.

Exp Neurol. 2008 Dec;214(2):147-59. doi: 10.1016/j.expneurol.2008.04.024. Epub 2008 May 1.

PMID:
19038604
24.

Magnetic resonance imaging versus histological assessment for estimation of lesion volume after experimental spinal cord injury. Laboratory investigation.

Ditor DS, John S, Cakiroglu J, Kittmer C, Foster PJ, Weaver LC.

J Neurosurg Spine. 2008 Sep;9(3):301-6.

PMID:
18928229
25.

An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury.

Bao F, Chen Y, Schneider KA, Weaver LC.

Exp Neurol. 2008 Dec;214(2):160-7. doi: 10.1016/j.expneurol.2008.09.006. Epub 2008 Sep 26.

PMID:
18926823
26.

Blockade of the 5-HT3 receptor for days causes sustained relief from mechanical allodynia following spinal cord injury.

Chen Y, Oatway MA, Weaver LC.

J Neurosci Res. 2009 Feb;87(2):418-24. doi: 10.1002/jnr.21860.

PMID:
18798253
27.

The systemic inflammatory response after spinal cord injury damages lungs and kidneys.

Gris D, Hamilton EF, Weaver LC.

Exp Neurol. 2008 May;211(1):259-70. doi: 10.1016/j.expneurol.2008.01.033. Epub 2008 Mar 4.

PMID:
18384773
28.

Transient blockage of the CD11d/CD18 integrin reduces contusion volume and macrophage infiltration after traumatic brain injury in rats.

Utagawa A, Bramlett HM, Daniels L, Lotocki G, Dekaban GA, Weaver LC, Dietrich WD.

Brain Res. 2008 May 1;1207:155-63. doi: 10.1016/j.brainres.2008.02.057. Epub 2008 Mar 5.

29.

Debate: "is increasing neuroinflammation beneficial for neural repair?".

Crutcher KA, Gendelman HE, Kipnis J, Perez-Polo JR, Perry VH, Popovich PG, Weaver LC.

J Neuroimmune Pharmacol. 2006 Sep;1(3):195-211. Epub 2006 May 23. Review. No abstract available.

PMID:
18040798
30.

Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat.

Ditor DS, John SM, Roy J, Marx JC, Kittmer C, Weaver LC.

J Neurosci Res. 2007 May 15;85(7):1458-67.

PMID:
17410603
31.

NGF mRNA is expressed in the dorsal root ganglia after spinal cord injury in the rat.

Brown A, Ricci MJ, Weaver LC.

Exp Neurol. 2007 May;205(1):283-6. Epub 2007 Feb 3.

PMID:
17335812
32.

Effects of a novel tripeptide on neurological outcomes after spinal cord injury.

John SM, Bao F, Chen Y, Mathison RD, Weaver LC.

Neuroreport. 2006 Nov 27;17(17):1793-6.

PMID:
17164666
33.

The cellular inflammatory response in human spinal cords after injury.

Fleming JC, Norenberg MD, Ramsay DA, Dekaban GA, Marcillo AE, Saenz AD, Pasquale-Styles M, Dietrich WD, Weaver LC.

Brain. 2006 Dec;129(Pt 12):3249-69. Epub 2006 Oct 28.

PMID:
17071951
35.

The tripeptide phenylalanine-(D) glutamate-(D) glycine modulates leukocyte infiltration and oxidative damage in rat injured spinal cord.

Bao F, John SM, Chen Y, Mathison RD, Weaver LC.

Neuroscience. 2006 Jul 7;140(3):1011-22. Epub 2006 Apr 3.

PMID:
16581192
36.

Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment.

Weaver LC, Gris D, Saville LR, Oatway MA, Chen Y, Marsh DR, Hamilton EF, Dekaban GA.

J Neurotrauma. 2005 Dec;22(12):1375-87.

PMID:
16379576
37.

Autonomic dysreflexia after spinal cord injury: central mechanisms and strategies for prevention.

Weaver LC, Marsh DR, Gris D, Brown A, Dekaban GA.

Prog Brain Res. 2006;152:245-63. Review.

PMID:
16198705
38.

Effects of spinal cord injury on synaptic inputs to sympathetic preganglionic neurons.

Llewellyn-Smith IJ, Weaver LC, Keast JR.

Prog Brain Res. 2006;152:11-26. Review.

PMID:
16198690
39.

Anti-CD11d antibody treatment reduces free radical formation and cell death in the injured spinal cord of rats.

Bao F, Dekaban GA, Weaver LC.

J Neurochem. 2005 Sep;94(5):1361-73. Epub 2005 Jun 30.

40.

Cellular imaging of inflammation after experimental spinal cord injury.

Dunn EA, Weaver LC, Dekaban GA, Foster PJ.

Mol Imaging. 2005 Jan-Mar;4(1):53-62.

PMID:
15967126
41.
42.
43.

A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment.

Saville LR, Pospisil CH, Mawhinney LA, Bao F, Simedrea FC, Peters AA, O'Connell PJ, Weaver LC, Dekaban GA.

J Neuroimmunol. 2004 Nov;156(1-2):42-57.

PMID:
15465595
44.
45.

The 5-HT3 receptor facilitates at-level mechanical allodynia following spinal cord injury.

Oatway MA, Chen Y, Weaver LC.

Pain. 2004 Jul;110(1-2):259-68.

PMID:
15275776
46.
47.

NGF message and protein distribution in the injured rat spinal cord.

Brown A, Ricci MJ, Weaver LC.

Exp Neurol. 2004 Jul;188(1):115-27.

PMID:
15191808
48.

Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function.

Gris D, Marsh DR, Oatway MA, Chen Y, Hamilton EF, Dekaban GA, Weaver LC.

J Neurosci. 2004 Apr 21;24(16):4043-51.

49.
50.

Autonomic dysreflexia after spinal cord transection or compression in 129Sv, C57BL, and Wallerian degeneration slow mutant mice.

Jacob JE, Gris P, Fehlings MG, Weaver LC, Brown A.

Exp Neurol. 2003 Sep;183(1):136-46.

PMID:
12957497

Supplemental Content

Loading ...
Support Center